Revance is a fast-growing global aesthetics, skincare, and therapeutics company with over 25 years of science-powered innovation. Formed through the merger of Revance Therapeutics and Crown Laboratories, their portfolio includes DAXXIFY, the first and only peptide-formulated neuromodulator with results lasting up to six months, the RHA Collection of dynamic hyaluronic acid fillers, and SkinPen, the number one microneedling device in the U.S.